BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$856M |
| 2 |
NVIDIA
NVDA
|
+$816M |
| 3 |
Visa
V
|
+$762M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$717M |
| 5 |
Amazon
AMZN
|
+$513M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$427M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$305M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$214M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$199M |
| 5 |
Bank of America
BAC
|
+$147M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.85% |
| 2 | Consumer Discretionary | 7.59% |
| 3 | Financials | 7.37% |
| 4 | Healthcare | 7.24% |
| 5 | Communication Services | 5.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3501
Petrobras Class A
PBR.A
$104B
| $16.6K | ﹤0.01% |
1,217
| – | – |
|
3502
Inovio Pharmaceuticals
INO
$93M
| $16.6K | ﹤0.01% |
2,051
+1,745
| +570% | +$18.4K |
|
|
VTNR
3503
DELISTED
Vertex Energy, Inc
VTNR
| $16.5K | ﹤0.01% |
17,449
-42,849
| -71% | -$50.3K |
|
|
HTT
3504
High Templar Tech Ltd
HTT
$391M
| $16.2K | ﹤0.01% |
8,201
-340
| -4% | -$709 |
|
3505
Mammoth Energy Services
TUSK
$154M
| $16.2K | ﹤0.01% |
4,937
-6,328
| -56% | -$21.7K |
|
3506
MeiraGTx Holdings
MGTX
$1.17B
| $16.2K | ﹤0.01% |
3,843
-15,399
| -80% | -$77.7K |
|
3507
Loar Holdings
LOAR
$6.93B
| $16K | ﹤0.01% |
+300
| New | +$16.3K |
|
3508
State Street SPDR FTSE International Government Inflation-Protected Bond ETF
WIP
$474M
| $16K | ﹤0.01% |
415
| – | – |
|
3509
Children's Place
PLCE
$53.4M
| $15.9K | ﹤0.01% |
1,950
-38,512
| -95% | -$365K |
|
3510
Inhibrx
INBX
$1.42B
| $15.7K | ﹤0.01% |
+1,105
| New | +$17.3K |
|
3511
Prairie Operating Co
PROP
$82.1M
| $15.6K | ﹤0.01% |
+1,442
| New | +$18.3K |
|
3512
Bakkt Inc
BKKT
$331M
| $15.6K | ﹤0.01% |
+823
| New | +$11.1K |
|
3513
Akebia Therapeutics
AKBA
$241M
| $15.4K | ﹤0.01% |
15,133
+14,962
| +8,750% | +$18.5K |
|
|
BLUE
3514
DELISTED
bluebird bio
BLUE
| $15.4K | ﹤0.01% |
783
-4,322
| -85% | -$86.6K |
|
3515
Trevi Therapeutics
TRVI
$2.59B
| $15.4K | ﹤0.01% |
5,166
-15,411
| -75% | -$42.8K |
|
|
EDN
3516
Edenor
EDN
$1.04B
| $15.3K | ﹤0.01% |
932
-2,244
| -71% | -$39.4K |
|
3517
Tootsie Roll Industries
TR
$3.02B
| $15.2K | ﹤0.01% |
528
-94
| -15% | -$2.65K |
|
3518
Accuray
ARAY
$32.9M
| $15.2K | ﹤0.01% |
8,362
-38,076
| -82% | -$72.6K |
|
|
VNET
3519
VNET Group
VNET
$2.12B
| $15.1K | ﹤0.01% |
7,226
| – | – |
|
3520
Nektar Therapeutics
NKTR
$2.57B
| $15K | ﹤0.01% |
805
+627
| +352% | +$13.2K |
|
3521
Korro Bio
KRRO
$196M
| $14.9K | ﹤0.01% |
+439
| New | +$24.3K |
|
|
NKGNW
3522
DELISTED
NKGen Biotech, Inc. Warrants
NKGNW
| $14.8K | ﹤0.01% |
150,000
| – | – |
|
|
KZIA
3523
Kazia Therapeutics
KZIA
$151M
| $14.5K | ﹤0.01% |
1,271
+299
| +31% | +$4.45K |
|
|
TOUR
3524
Tuniu
TOUR
$54.4M
| $14.4K | ﹤0.01% |
1,720
+990
| +136% | +$9.22K |
|
3525
Comp X International
CIX
$390M
| $14.3K | ﹤0.01% |
579
-4,892
| -89% | -$136K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2024 Portfolio in Review
As of Q2 2024, BNP Paribas Financial Markets held 4,270 positions worth $123B, up 7.8% from $114B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BNP Paribas Financial Markets deployed $7.82B of net new capital in Q2 2024, opening 230 new positions and adding to 1,339 existing holdings. Its largest new stake was Flutter Entertainment: 782,106 shares worth $143M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 19% a quarter earlier, followed by Consumer Discretionary and Financials.
On the sell side, the largest reduction was Apple, an estimated $427M trimmed.
- BNP Paribas Financial Markets's largest Q2 2024 buy was Flutter Entertainment: 782,106 shares worth $143M.
- BNP Paribas Financial Markets added most to Microsoft in Q2 2024, an estimated $856M increase.
- BNP Paribas Financial Markets's biggest Q2 2024 reduction was Apple, cutting an estimated $427M.
- BNP Paribas Financial Markets fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $214M.
- BNP Paribas Financial Markets's ten largest holdings make up 19% of its $123B portfolio in Q2 2024.
- BNP Paribas Financial Markets opened 230 new positions and closed 234 in Q2 2024.
- BNP Paribas Financial Markets's portfolio value rose 7.8% quarter-over-quarter to $123B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2024, filed 13 Aug 2024.